Publications by authors named "G B Filomena"

The Y chromosome (ChrY) is essential for male sex determination and spermatogenesis. However, recent studies have revealed its broader role in various physiological processes and disease susceptibility, including cancer. A comprehensive literature review was conducted using databases like MEDLINE, Scopus, Web of Science, and Google Scholar.

View Article and Find Full Text PDF

Background And Objective: The introduction of the Hugo RAS system represents a recent innovation in robotic surgery. The potential benefits and limitations of this system and its integration into clinical practice in urology have yet to be fully delineated. Our objective was to assess surgical, early oncological, and functional outcomes in studies comparing robot-assisted radical prostatectomy (RARP) performed with the new Hugo RAS system and the well-established da Vinci surgical system.

View Article and Find Full Text PDF

The Hugo™ Robotic-Assisted Surgery (Hugo™ RAS) system represents a novel advancement in robotic surgical technology. Despite this, there remains a scarcity of data regarding extraperitoneal robot-assisted radical prostatectomy (eRARP) using this system. We conducted a prospective study at Ospedale Regionale "F.

View Article and Find Full Text PDF

The world of complementary and alternative medicine (CAM) encompasses a wide range of practices, treatments, and products that fall outside the realm of conventional (mainstream) medicine. The use of complementary and CAM has become increasingly popular in Western nations. People are turning to CAM for a variety of reasons, including managing chronic diseases, relieving symptoms of various conditions, and improving their overall health and well-being.

View Article and Find Full Text PDF
Article Synopsis
  • The study compared robot-assisted radical cystectomy (RARC) to open radical cystectomy (ORC) in terms of surgical and cancer outcomes using specific criteria called trifecta and pentafecta.
  • Data from 41 patients undergoing RARC were compared to 330 patients who had ORC, focusing on factors like surgical margins, complications, and cancer recurrence.
  • While there were no significant differences in success rates between the two methods, RARC demonstrated a notable advantage with less blood loss during surgery.
View Article and Find Full Text PDF